Neonc Technologies Holdings, Inc.
NeOnc Technologies, Inc. (Nasdaq: NTHI) is a clinical-stage biopharmaceutical company developing treatments and drug-delivery methods for cancers in the brain. Its two lead candidates are NEO100, a purified form of perillyl alcohol administered intranasally, and NEO212, an oral molecule that combines perillyl alcohol… From the company’s description.
In fiscal 2025, Neonc Technologies Holdings, Inc. reported revenue of $0.04M and a net loss of $62.15M. Operations used $20.36M in cash.
Dotted labels explain each measure. is shown separately from the annual figures.
What Neonc Technologies Holdings, Inc. does
In the company’s own words
NeOnc Technologies, Inc. (Nasdaq: NTHI) is a clinical-stage biopharmaceutical company developing treatments and drug-delivery methods for cancers in the brain. Its two lead candidates are NEO100, a purified form of perillyl alcohol administered intranasally, and NEO212, an oral molecule that combines perillyl alcohol with the chemotherapy drug temozolomide. NEO100 is being studied in Phase II trials for recurrent high-grade gliomas and meningioma; NEO212 is in a Phase I/II trial for primary brain tumors and brain metastases. The company also investigates NEO100 as a potential vehicle for delivering other medicines to the brain, including in preclinical work on Parkinson’s disease and intra-arterial delivery. Its research targets primary brain cancers and tumors that have spread to the brain from cancers elsewhere in the body. NeOnc has no commercial products or sales and marketing infrastructure. In 2025, it acquired intellectual property covering AI-driven drug discovery, 3D bioprinting and quantum molecular modeling to support research and development.
Company details
- Sector
- Health Care
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- CALABASAS, CA
- Fiscal year end
- December
- CIK
- 1979414
- SIC
- 2834
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Neonc Technologies Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Neonc Technologies Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Neonc Technologies Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Neonc Technologies Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Neonc Technologies Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”